Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 39: 2305-2308, 1993;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Phillipou, G.
Right arrow Articles by Phillips, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Phillipou, G.
Right arrow Articles by Phillips, P. J.

Clinical Chemistry, Vol 39, 2305-2308, Copyright © 1993 by American Association for Clinical Chemistry

Intraindividual variation of glycohemoglobin: implications for interpretation and analytical goals

G Phillipou and PJ Phillips
Endocrine and Diabetes Service, Queen Elizabeth Hospital, Woodville, Australia.

Intraindividual variation (CVi) for glycohemoglobin (GHb) was estimated from serial measurements in patients with diabetes in either stable or variable clinical control. GHb determinations were performed by an affinity column procedure with an analytical imprecision of 4.9% (weighted average; GHb 8.2-14.7%). Within the groups of patients, both a short- (28-32 days) and long-term (approximately 85 days) sampling protocol was used. The derived CVi for each category was 4.2% (n = 16, stable, short-term), 7.1% (n = 23, stable, long-term), 5.1% (n = 13, variable, short-term), and 9.8% (n = 21, variable, long-term). The mean GHb within each category was similar (approximately 11%), and there was no statistically significant difference in GHb values between categories. The results establish that the CVi for GHb is affected by both clinical control and the sampling time interval. These findings have important implications for the estimation of significant differences between serial GHb measurements and the setting of appropriate analytical precision goals.


The following articles in journals at HighWire Press have cited this article:


Home page
Ann Clin BiochemHome page
P. Desmeules, J. Cousineau, and P. Allard
Biological variation of glycated haemoglobin in a paediatric population and its application to calculation of significant change between results
Ann Clin Biochem, January 1, 2010; 47(1): 35 - 38.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
E. Selvin, H. Zhu, and F. L. Brancati
Elevated A1C in Adults Without a History of Diabetes in the U.S.
Diabetes Care, May 1, 2009; 32(5): 828 - 833.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
S. Skeie, C. Perich, C. Ricos, A. Araczki, A. R. Horvath, W. P. Oosterhuis, T. Bubner, G. Nordin, R. Delport, G. Thue, et al.
Postanalytical External Quality Assessment of Blood Glucose and Hemoglobin A1c: An International Survey
Clin. Chem., July 1, 2005; 51(7): 1145 - 1153.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
J. Trape, J. Perez de Olaguer, J. Buxo, and L. Lopez
Biological Variation of Tumor Markers and Its Application in the Detection of Disease Progression in Patients with Non-Small Cell Lung Cancer
Clin. Chem., January 1, 2005; 51(1): 219 - 222.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
J. Trape, J. M. Botargues, F. Porta, C. Ricos, J. M. Badal, R. Salinas, M. Sala, and A. Roca
Reference Change Value for {alpha}-Fetoprotein and Its Application in Early Detection of Hepatocellular Carcinoma in Patients with Hepatic Disease
Clin. Chem., July 1, 2003; 49(7): 1209 - 1211.
[Full Text] [PDF]


Home page
ANN INTERN MEDHome page
R G. Barr, D. M. Nathan, J. B. Meigs, and D. E. Singer
Tests of Glycemia for the Diagnosis of Type 2 Diabetes Mellitus
Ann Intern Med, August 20, 2002; 137(4): 263 - 272.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
G. Phillipov and P. J. Phillips
Components of Total Measurement Error for Hemoglobin A1c Determination
Clin. Chem., October 1, 2001; 47(10): 1851 - 1853.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
S. Skeie, G. Thue, and S. Sandberg
Interpretation of Hemoglobin A1c (HbA1c) Values among Diabetic Patients: Implications for Quality Specifications for HbA1c
Clin. Chem., July 1, 2001; 47(7): 1212 - 1217.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
I. Gibb, A. Parnham, M. Fonfrede, and F. Lecock
Multicenter Evaluation of Tosoh Glycohemoglobin Analyzer
Clin. Chem., October 1, 1999; 45(10): 1833 - 1841.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
E. Gerlo and F. Gorus
Calibration of ion-exchange HPLC measurements of glycohemoglobin: effect on interassay precision
Clin. Chem., December 1, 1997; 43(12): 2353 - 2357.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by the American Association for Clinical Chemistry.